To demonstrate whether the HBV-mediated liver toxicity may have contributed to the worse outcome of NHL patients, the 135 HBV-infected patients were classified into two groups, namely the normal and abnormal liver function groups, according to the ALT/AST levels examined before chemotherapy. This evidence concerns the gene GPT and non-Hodgkin lymphoma.